Skip to main content
. Author manuscript; available in PMC: 2022 May 27.
Published in final edited form as: Nat Genet. 2016 May 2;48(6):634–639. doi: 10.1038/ng.3561

Table 1.

Association of rare and low-frequency variants with blood lipids

Non-HDL-C (mmol/L)
n = 119,146
HDL-C (mmol/L)
n = 119,514
Triglycerides (% change)
n = 80,111
Gene Variant rsID A1/A2 A2 (%) Effect (95% Cl) P Effect (95% Cl) P Effect (95% Cl) P
PCSK9 p.Arg46Leu rs11591147 G/T 1.17 −0.58
(−0.65, −0.51)
1.2 × 10−64 0.031
(0.003, 0.058)
0.028 −1.7
(−4.7, 1.3)
0.25
ANGPTL3 a Splice region rs372257803 T/C 0.27 −0.30
(−0.44, −0.17)
1.4 × 10−5 −0.053
(−0.108, 0.003)
0.063 −16.9
(−21.9, −11.6)
5.7 × 10−9
ANGPTL3 a p.Asp290His 1:62602317 G/C 0.49 −0.38
(−0.48, −0.29)
7.2 × 10−15 −0.043
(−0.082, −0.003)
0.033 −20.9
(−24.4, −17.3)
1.6 × 10−24
APOB p.His1923Arg rs533617 T/C 4.52 −0.21
(−0.24, −0.17)
1.3 × 10−32 0.047
(0.033, 0.061)
4.6 × 10−11 −6.0
(−8.7, −3.1)
4.7 × 10−5
APOB a p.Gly1829Glufs 2:21011381 TC/T 0.007 −3.28
(−4.24, −2.32)
1.7 × 10−11 0.33
(−0.08, 0.73)
0.12 −65.3
(−77.7, −46.1)
2.6 × 10−6
APOB a p.Leu1550Arg 2:21012219 A/C 0.017 −2.04
(−2.60, −1.48)
7.8 × 10−13 0.34
(0.11, 0.57)
0.004 −35.0
(−49.1, −17.0)
5.6 × 10−4
APOB a p.Gln725 rs374473614 G/A 0.02 −3.09
(−3.63, −2.55)
3.2 × 10−29 0.31
(0.09, 0.53)
5.9 × 10−3 −63.2
(−71.0, −53.2)
3.4 × 10−16
LPL p.Asp36Asn rs1801177 G/A 1.22 0.054
(−0.010, 0.119)
0.099 −0.086
(−0.112, −0.060)
1.4 × 10−10 9.5
(6.4, 12.7)
7.0 × 10−10
LPL p.Asn318Ser rs268 A/G 1.14 0.042
(−0.024, 0.109)
0.21 −0.10
(−0.13, −0.08)
1.1 × 10−13 12.0
(8.7, 15.4)
1.5 × 10−13
ABCA1 a Splice region rs188308962 A/G 0.35 −0.17
(−0.30, −0.05)
6.3 × 10−3 −0.23
(−0.28, −0.18)
2.2 × 10−19 −4.2
(−9.3, 1.3)
0.13
NR1H3 a Splice region rs200557846 C/A 0.61 −0.006
(−0.096, 0.084)
0.90 0.12
(0.08, 0.16)
7.2 × 10−10 −5.6
(−9.4, −1.7)
5.6 × 10−3
APOC3 Splice donor rs138326449 G/A 0.23 −0.51
(−0.66, −0.36)
2.4 × 10−11 0.34
(0.28, 0.40)
1.2 × 10−27 −44.6
(−48.3, −40.8)
7.2 × 10−66
APOA1 a p.Val43Leu 11:116837074 C/G 0.70 −0.16
(−0.25, −0.08)
2.5 × 10−4 0.17
(0.14, 0.21)
4.5 × 10−22 5.2
(1.2, 9.4)
0.01
MAP1A p.Pro2349Leu rs55707100 C/T 2.76 0.017
(−0.028, 0.061)
0.47 −0.046
(−0.063, −0.028)
3.1 × 10−7 6.8
(4.7, 8.9)
3.8 × 10−11
LIPC a p.Arg208His rs200684324 G/A 0.18 0.15
(−0.02, 0.31)
0.079 0.19
(0.13, 0.26)
1.3 × 10−8 14.2
(6.1, 22.8)
4.1 × 10−4
CETP a p.Val39Glyfs 16:56962092 T/TG 0.06 −0.53
(−0.81, −0.25)
2.4 × 10−4 0.40
(0.29, 0.52)
5.4 × 10−12 −5.0
(−16.6, 8.2)
0.44
CETP a p.Glu443Lys rs536221680 G/A 0.29 −0.31
(−0.45, −0.18)
6.3 × 10−6 0.33
(0.28, 0.39)
4.4 × 10−32 −0.2
(−5.6, 5.6)
0.96
CETP p.Arg468Gln rs1800777 G/A 3.57 0.10
(0.06, 0.13)
1.3 × 10−6 −0.18
(−0.19, −0.16)
7.4 × 10−108 2.2
(0.5, 4.0)
0.01
LCAT p.Ser232Thr rs4986970 A/T 2.90 0.00
(−0.043, 0.043)
0.99 −0.048
(−0.066, −0.031)
5.2 × 10−8 0.4
(−1.5, 2.4)
0.67
CD300LG p.Arg82Cys rs72836561 C/T 3.36 0.045
(0.005, 0.084)
0.026 −0.087
(−0.103, −0.071)
3.2 × 10−26 6.7
(4.8, 8.6)
7.3 × 10−13
ABCA6 p.Cys1359Arg rs77542162 A/G 2.55 0.15
(0.10, 0.19)
5.4 × 10−11 −0.007
(−0.025, 0.010)
0.41 −2.6
(−4.5, −0.6)
0.01
LIPG p.Asn396Ser rs77960347 A/G 1.17 0.16
(0.10, 0.23)
1.2 × 10−6 0.13
(0.10, 0.15)
1.0 × 10−20 3.5
(0.6, 6.6)
0.019
ANGPTL4 p.Glu40Lys rs116843064 G/A 2.39 −0.16
(−0.21, −0.11)
8.7 × 10−11 0.10
(0.08, 0.12)
3.9 × 10−23 −11.9
(−13.7, −9.9)
1.4 × 10−30
LDLR Splice donor rs200238879 T/C 0.056 1.39
(1.12, 1.66)
1.7 × 10−23 −0.054
(−0.165, 0.057)
0.34 −12.0
(−22.1, −0.6)
0.04
LDLR a Splice region rs72658867 G/A 2.22 −0.42
(−0.47, −0.37)
5.2 × 10−63 0.029
(0.009, 0.049)
4.2 × 10−3 −1.8
(−3.9, 0.4)
0.11
APOC1 a Intronic rs539667984 G/C 0.82 −0.12
(−0.20., −0.04)
3.0 × 10−3 0.11
(0.07, 0.14)
1.8 × 10−10 −13.6
(−16.7, −10.4)
4.0 × 10−15
HNF4A p.Thr139lle rs1800961 C/T 4.60 −0.04
(−0.072, −0.008)
0.013 −0.065
(−0.079, −0.051)
5.2 × 10−20 1.0
(−0.5, 2.5)
0.21

Effect (in mmol/L or percent change for log-transformed triglyceride levels) is given with respect to allele A2. Variant type was determined on the basis of information from Ensembl release 70 using Variant Effect Predictor (VEP) version 2.8. For variants without an rsID, the chromosomal position (chr:position) in Build 38 of the human reference sequence is given. Non-HDL-C, non-HDL cholesterol; HDL-C, HDL cholesterol; A1/A2, major allele/minor allele; A2 (%), frequency of allele A2; Cl, confidence interval.

a

New sequence variant.